AM-2201

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
AM-2201
AM-2201.svg
Systematic (IUPAC) name
1-[(5-Fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone
Clinical data
Legal status
Identifiers
CAS Number 335161-24-5 YesY
ChemSpider 24751884 YesY
Chemical data
Formula C24H22FNO
Molecular mass 359.44 g/mol
  • O=C(C1=CN(CCCCCF)C2=C1C=CC=C2)C3=CC=CC4=C3C=CC=C4
  • InChI=1S/C24H22FNO/c25-15-6-1-7-16-26-17-22(20-12-4-5-14-23(20)26)24(27)21-13-8-10-18-9-2-3-11-19(18)21/h2-5,8-14,17H,1,6-7,15-16H2 YesY
  • Key:ALQFAGFPQCBPED-UHFFFAOYSA-N YesY
  (verify)

AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor.[1] It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.

Hazards

Convulsions have been reported[2] including at doses as low as 10 mg.[3]

Recreational use of AM-2201 in the United States has led to it being specifically listed in a proposed 2011 amendment to the Controlled Substances Act, aiming to add a number of synthetic drugs into Schedule I.[4] The acute toxicity and long term side effects associated with the use of AM-2201 are acute kidney failure, brain damage, strokes, convulsions, seizures, rhabdomyolysis, and death.,,,[5][6][7][8][9]

Pharmacology

AM-2201 is a full agonist for cannabinoid receptors. Affinities are: with a Ki of 1.0 nM at CB1 and 2.6 nM at CB2.[10] The 4-methyl functional analog MAM-2201 probably has similar affinities.[original research?] AM-2201 has an EC50 of 38 nM for human CB1 receptors, and 58 nM for human CB2 receptors.[11] AM-2201 produces bradycardia and hypothermia in rats at doses of 0.3–3 mg/kg, comparable to the potency of JWH-018 in rats, suggesting potent cannabinoid-like activity.[11]

Pharmacokinetics

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

See also: JWH-018 § Pharmacokinetics

AM-2201 metabolism differs only slightly from that of JWH-018. AM-2201 N-dealkylation produces fluoropentane instead of pentane (or plain alkanes in general).[citation needed]

Detection

A forensic standard of AM-2201 is available, and the compound has been posted on the Forendex website of potential drugs of abuse.[12]

See also

References

  1. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  4. ↑ Synthetic Drug Control Act of 2011. H.R. 1254, 112th Congress, 1st Session (2011).
  5. ↑ Acute Kidney Injury Associated with Synthetic Cannabinoid Use, Multiple States, 2012. CDC morbitidy and mortality weekly report 2012.
  6. ↑ Forbes Synthetic Marijuana May Cause Psychosis, Brain and Kidney Damage. Forbes report, Synthetic Marijuana Linked to Psychosis, Brain, and Kidney Damage. 2013
  7. ↑ PubMed Report, 2015. PubMed Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use, 2015
  8. ↑ Bowling Green Daily News Report 2011. Bowling Green Daily News Report, 2011
  9. ↑ Phys.org Report 2013. Phys.org Website, 2013
  10. ↑ WO patent 0128557, Makriyannis A, Deng H, "Cannabimimetic indole derivatives", granted 2001-06-07 
  11. ↑ 11.0 11.1 Lua error in package.lua at line 80: module 'strict' not found.
  12. ↑ Southern Association of Forensic Scientists
Retrieved from "https://infogalactic.com/w/index.php?title=AM-2201&oldid=721691002"